Fennec Pharmaceuticals Ownership
| FENC Stock | USD 6.67 0.05 0.76% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 27 M | Current Value 27 M | Avarage Shares Outstanding 15.4 M | Quarterly Volatility 8.4 M |
Fennec |
Fennec Stock Ownership Analysis
About 16.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Fennec Pharmaceuticals had 1:3 split on the 5th of September 2014. Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Fennec Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people. To learn more about Fennec Pharmaceuticals call Rostislav Raykov at 919 636 4530 or check out https://www.fennecpharma.com.Besides selling stocks to institutional investors, Fennec Pharmaceuticals also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Fennec Pharmaceuticals' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Fennec Pharmaceuticals' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Fennec Pharmaceuticals Quarterly Liabilities And Stockholders Equity |
|
Fennec Pharmaceuticals Insider Trades History
About 16.0% of Fennec Pharmaceuticals are currently held by insiders. Unlike Fennec Pharmaceuticals' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Fennec Pharmaceuticals' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Fennec Pharmaceuticals' insider trades
Fennec Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Fennec Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fennec Pharmaceuticals backward and forwards among themselves. Fennec Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Fennec Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Gendell Jeffrey L | 2024-12-31 | 199.3 K | Lion Point Capital, Lp | 2024-12-31 | 195.7 K | Northern Trust Corp | 2024-12-31 | 136.8 K | Goldman Sachs Group Inc | 2024-12-31 | 71.2 K | Charles Schwab Investment Management Inc | 2024-12-31 | 61.1 K | Bank Of New York Mellon Corp | 2024-12-31 | 52.1 K | Hartford Financial Management Inc. | 2024-12-31 | 49.8 K | Bnp Paribas Arbitrage, Sa | 44.6 K | Clayton Partners, Llc | 2024-12-31 | 40.5 K | Southpoint Capital Advisors Lp | 2024-12-31 | 4.1 M | Sonic Gp Llc | 2024-12-31 | 2.4 M |
Fennec Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Fennec Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Fennec Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Fennec Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Fennec Pharmaceuticals Outstanding Bonds
Fennec Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fennec Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fennec bonds can be classified according to their maturity, which is the date when Fennec Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Fennec Pharmaceuticals Corporate Filings
8K | 10th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 6th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.